Proposed Substances To Be Evaluated for Set 31 Toxicological Profiles, 14900-14901 [2017-05736]
Download as PDF
<![CDATA[
14900
Federal Register / Vol. 82, No. 55 / Thursday, March 23, 2017 / Notices
Dated: January 24, 2017.
Delores Barber,
Director, Information Technology and
Resources Management Division, Office of
Pesticide Programs.
stocks set forth in Unit VI. will be a
violation of FIFRA.
V. What is the Agency’s authority for
taking this action?
Section 6(f)(1) of FIFRA (7 U.S.C.
136d(f)(1)) provides that a registrant of
a pesticide product may at any time
request that any of its pesticide
registrations be canceled or amended to
terminate one or more uses. FIFRA
further provides that, before acting on
the request, EPA must publish a notice
of receipt of any such request in the
Federal Register. Thereafter, following
the public comment period, the EPA
Administrator may approve such a
request. The notice of receipt for this
action was published for comment in
the Federal Register of November 18,
2016 (81 FR 81761) (FRL–9953–55). The
comment period closed on December
19, 2016.
sradovich on DSK3GMQ082PROD with NOTICES
VI. Provisions for Disposition of
Existing Stocks
Existing stocks are those stocks of
registered pesticide products which are
currently in the United States and
which were packaged, labeled, and
released for shipment prior to the
effective date of the action. The existing
stocks provision for the products subject
to this order is as follows.
For voluntary cancellations, the
registrants may continue to sell and
distribute existing stocks of products
listed in Table 1 until March 23, 2018,
which is 1 year after publication of this
cancellation order in the Federal
Register. Thereafter, the registrants are
prohibited from selling or distributing
products listed in Table 1 of Unit II,
except for export in accordance with
FIFRA section 17 (7 U.S.C. 136o) or for
proper disposal.
Now that EPA has approved product
labels reflecting the requested
amendments to terminate uses,
registrants are permitted to sell or
distribute products listed in Table 2 of
Unit II, under the previously approved
labeling until September 24, 2018, a
period of 18 months after publication of
the cancellation order in this Federal
Register, unless other restrictions have
been imposed. Thereafter, registrants
will be prohibited from selling or
distributing the products whose labels
include the terminated uses identified
in Table 2 of Unit II, except for export
consistent with FIFRA section 17 or for
proper disposal.
Authority: 7 U.S.C. 136 et seq.
VerDate Sep<11>2014
17:13 Mar 22, 2017
Jkt 241001
[FR Doc. 2017–05700 Filed 3–22–17; 8:45 am]
BILLING CODE 6560–50–P
FEDERAL DEPOSIT INSURANCE
CORPORATION
Sunshine Act Meeting
Pursuant to the provisions of the
‘‘Government in the Sunshine Act’’ (5
U.S.C. 552b), notice is hereby given that
at 10:26 a.m. on Tuesday, March 21,
2017, the Board of Directors of the
Federal Deposit Insurance Corporation
met in closed session to consider
matters related to the Corporation’s
supervision, corporate, and resolution
activities.
In calling the meeting, the Board
determined, on motion of Vice
Chairman Thomas M. Hoenig, seconded
by Director Thomas J. Curry
(Comptroller of the Currency),
concurred in by Director Richard
Cordray (Director, Consumer Financial
Protection Bureau), and Chairman
Martin J. Gruenberg, that Corporation
business required its consideration of
the matters which were to be the subject
of this meeting on less than seven days’
notice to the public; that no earlier
notice of the meeting was practicable;
that the public interest did not require
consideration of the matters in a
meeting open to public observation; and
that the matters could be considered in
a closed meeting by authority of
subsections (c)(2), (c)(4), (c)(6), (c)(8),
(c)(9)(A)(ii), (c)(9)(B), and (c)(10) of the
‘‘Government in the Sunshine Act’’ (5
U.S.C. 552b(c)(2), (c)(4), (c)(6), (c)(8),
(c)(9)(A)(ii), (c)(9)(B), and (c)(10).
Dated: March 21, 2017.
Federal Deposit Insurance Corporation.
Robert E. Feldman,
Executive Secretary.
[FR Doc. 2017–05890 Filed 3–21–17; 4:15 pm]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Toxic Substances and
Disease Registry
[Docket No. ATSDR–2017–0003]
Proposed Substances To Be Evaluated
for Set 31 Toxicological Profiles
Agency for Toxic Substances
and Disease Registry (ATSDR),
AGENCY:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Department of Health and Human
Services (HHS).
ACTION: Notice; request for comments.
The Agency for Toxic
Substances and Disease Registry
(ATSDR) located in the Department of
Health and Human Services (HHS) is
initiating the development of its 31st set
of toxicological profiles (Set 31).
Today’s announcement invites
voluntary public nominations of
substances for profile development.
ATSDR is soliciting public nominations
of substances found on the Substance
Priority List (SPL) at https://
www.atsdr.cdc.gov/spl.
DATES: Comments must be submitted
April 24, 2017.
ADDRESSES: You may submit
nominations, identified by Docket No.
ATSDR–2017–0003, by any of the
following methods:
*Internet: Access the Federal
eRulemaking portal at https://
www.regulations.gov. Follow the
instructions for submitting comments.
*Mail: Division of Toxicology and
Human Health Sciences, 1600 Clifton
Rd. NE., MS F–57, Atlanta, GA 30329.
Instructions: All submissions must
include the agency name and docket
number for this notice. All relevant
comments will be posted without
change. This means that no confidential
business information or other
confidential information should be
submitted in response to this notice.
Refer to the section Submission of
Nominations (below) for the specific
information required.
FOR FURTHER INFORMATION CONTACT: For
further information, please contact
Commander Jessilynn B. Taylor,
Division of Toxicology and Human
Health Sciences, 1600 Clifton Rd. NE.,
MS F–57, Atlanta, GA 30329, Email:
jxt1@cdc.gov; phone: 770–488–3313.
SUPPLEMENTARY INFORMATION: The
Superfund Amendments and
Reauthorization Act of 1986 (SARA) [42
U.S.C. 9601 et seq.] amended the
Comprehensive Environmental
Response, Compensation, and Liability
Act of 1980 (CERCLA or Superfund) [42
U.S.C. 9601 et seq.] by establishing
certain requirements for ATSDR and the
U.S. Environmental Protection Agency
(EPA) with regard to hazardous
substances most commonly found at
facilities on the CERCLA National
Priorities List (NPL). Among these
statutory requirements is a mandate for
the Administrator of ATSDR to prepare
toxicological profiles for each substance
included on the SPL. This list identifies
275 hazardous substances that ATSDR
and EPA have determined pose the most
SUMMARY:
E:\FR\FM\23MRN1.SGM
23MRN1
Federal Register / Vol. 82, No. 55 / Thursday, March 23, 2017 / Notices
nomination period. Nominations
received after the closing date will be
marked as late and may be considered
only if time and resources permit.
significant current potential threat to
human health. The availability of the
revised list of the 275 SPL substances
was announced in April, 2015 on the
following Web site: https://
www.atsdr.cdc.gov/spl.
sradovich on DSK3GMQ082PROD with NOTICES
Substances To Be Evaluated for Set 31
Toxicological Profiles
Each year, ATSDR develops a list of
substances to be considered for
toxicological profile development. The
Set 31 nomination process includes
consideration of all substances on
ATSDR’s SPL, as well as other
substances nominated by the public.
The 275 substances on the SPL will be
considered for Set 31 Toxicological
Profile development. This list may be
found at the following Web site: https://
www.atsdr.cdc.gov/spl.
Submission of Nominations for the
Evaluation of Set 31 Proposed
Substances
ATSDR also will consider the
nomination of any substance that is not
on the SPL under the authority of the
Comprehensive, Environmental
Response, Compensation, and Liability
Act (CERCLA) to ‘‘. . . establish and
maintain an inventory of literature,
research, and studies on the health
effects of toxic substances’’ under
CERCLA Section 104(i)(1)(B), to respond
to requests for consultation under
section 104(i)(4), and to support the sitespecific response actions conducted by
ATSDR, as otherwise necessary.
Today’s document invites voluntary
public nominations for substances
included on the SPL and for substances
not listed on the SPL. All nominations
should include the full name of the
nominator, affiliation, and email
address. When nominating a non-SPL
substance, please include the rationale
for the nomination. Please note that
email addresses will not be posted in
the docket found at
www.regulations.gov.
ATSDR will evaluate all data and
information associated with nominated
substances and will determine the final
list of substances to be chosen for
toxicological profile development.
Substances will be chosen according to
ATSDR’s specific guidelines for
selection. These guidelines can be found
in the Selection Criteria announced in
the Federal Register on May 7, 1993 (58
FR 27286). A hard copy of the Selection
Criteria is available upon request or may
be accessed at: https://
www.atsdr.cdc.gov/toxprofiles/
guidance/criteria_for_selecting_tp_
support.pdf.
Please ensure that your comments are
submitted within the specified
VerDate Sep<11>2014
17:13 Mar 22, 2017
Jkt 241001
Pamela I. Protzel Berman,
Associate Director, Office of Policy, Planning
and Evaluation, National Center for
Environmental Health, Agency for Toxic
substances and Disease Registry.
[FR Doc. 2017–05736 Filed 3–22–17; 8:45 am]
BILLING CODE 4163–70–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns the Centers for Disease Control
and Prevention (CDC) initial review of
applications in response to Funding
Opportunity Announcement (FOA)
GH14–002, Addressing Emerging
Infectious Diseases in Bangladesh; and
FOA GH16–003, Conducting Public
Health Research in Thailand: Technical
collaboration with the Ministry of
Public Health in the Kingdom of
Thailand (MOPH).
SUMMARY: This publication corrects a
notice that was published in the Federal
Register on March 9, 2017 Volume 82,
Number 45, page 13119. The meeting
announcement and matters for
discussion should read as follows:
The meeting announced below
concerns the Centers for Disease Control
and Prevention (CDC) initial review of
applications in response to Funding
Opportunity Announcements (FOA)
GH13–001, Strengthening Disease
Prevention Research Capacity for Public
Health Action in Guatemala and the
Central American Region; FOA GH14–
002, Addressing Emerging Infectious
Diseases in Bangladesh; and FOA
GH16–003, Conducting Public Health
Research in Thailand: Technical
collaboration with the Ministry of
Public Health in the Kingdom of
Thailand (MOPH).
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Strengthening Disease Prevention
Research Capacity for Public Health
Action in Guatemala and the Central
American Region’’, FOA GH13–001;
‘‘Addressing Emerging Infectious
Diseases in Bangladesh’’, FOA GH14–
002; and ‘‘Conducting Public Health
Research in Thailand: Technical
PO 00000
Frm 00037
Fmt 4703
Sfmt 9990
14901
collaboration with the Ministry of
Public Health in the Kingdom of
Thailand (MOPH)’’, FOA GH16–003.
FOR FURTHER INFORMATION CONTACT:
Hylan Shoob, Scientific Review Officer,
Center for Global Health (CGH) Science
Office, CGH, CDC, 1600 Clifton Road
NE., Mailstop D–69, Atlanta, Georgia
30033, Telephone: (404) 639–4796,
HMS4@CDC.GOV.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2017–05733 Filed 3–22–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Clinical Laboratory Improvement
Advisory Committee (CLIAC)
Notice of Cancellation: This notice
was published in the Federal Register
on March 9, 2017, Volume 82, Number
45, page 13121. The meeting previously
scheduled to convene on April 12–13,
2017, has been canceled.
Contact Person for Additional
Information: Nancy Anderson, Chief,
Laboratory Practice Standards Branch,
Division of Laboratory Systems, Center
for Surveillance, Epidemiology and
Laboratory Services, Office of Public
Health Scientific Services, CDC, 1600
Clifton Road NE., Mailstop F–11,
Atlanta, Georgia 30329–4018; telephone
(404) 498–2741; or via email at
NAnderson@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2017–05731 Filed 3–22–17; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\23MRN1.SGM
23MRN1
]]>Agencies
[Federal Register Volume 82, Number 55 (Thursday, March 23, 2017)]
[Notices]
[Pages 14900-14901]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-05736]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Toxic Substances and Disease Registry
[Docket No. ATSDR-2017-0003]
Proposed Substances To Be Evaluated for Set 31 Toxicological
Profiles
AGENCY: Agency for Toxic Substances and Disease Registry (ATSDR),
Department of Health and Human Services (HHS).
ACTION: Notice; request for comments.
-----------------------------------------------------------------------
SUMMARY: The Agency for Toxic Substances and Disease Registry (ATSDR)
located in the Department of Health and Human Services (HHS) is
initiating the development of its 31st set of toxicological profiles
(Set 31). Today's announcement invites voluntary public nominations of
substances for profile development. ATSDR is soliciting public
nominations of substances found on the Substance Priority List (SPL) at
https://www.atsdr.cdc.gov/spl.
DATES: Comments must be submitted April 24, 2017.
ADDRESSES: You may submit nominations, identified by Docket No. ATSDR-
2017-0003, by any of the following methods:
*Internet: Access the Federal eRulemaking portal at https://www.regulations.gov. Follow the instructions for submitting comments.
*Mail: Division of Toxicology and Human Health Sciences, 1600
Clifton Rd. NE., MS F-57, Atlanta, GA 30329.
Instructions: All submissions must include the agency name and
docket number for this notice. All relevant comments will be posted
without change. This means that no confidential business information or
other confidential information should be submitted in response to this
notice. Refer to the section Submission of Nominations (below) for the
specific information required.
FOR FURTHER INFORMATION CONTACT: For further information, please
contact Commander Jessilynn B. Taylor, Division of Toxicology and Human
Health Sciences, 1600 Clifton Rd. NE., MS F-57, Atlanta, GA 30329,
Email: jxt1@cdc.gov; phone: 770-488-3313.
SUPPLEMENTARY INFORMATION: The Superfund Amendments and Reauthorization
Act of 1986 (SARA) [42 U.S.C. 9601 et seq.] amended the Comprehensive
Environmental Response, Compensation, and Liability Act of 1980 (CERCLA
or Superfund) [42 U.S.C. 9601 et seq.] by establishing certain
requirements for ATSDR and the U.S. Environmental Protection Agency
(EPA) with regard to hazardous substances most commonly found at
facilities on the CERCLA National Priorities List (NPL). Among these
statutory requirements is a mandate for the Administrator of ATSDR to
prepare toxicological profiles for each substance included on the SPL.
This list identifies 275 hazardous substances that ATSDR and EPA have
determined pose the most
[[Page 14901]]
significant current potential threat to human health. The availability
of the revised list of the 275 SPL substances was announced in April,
2015 on the following Web site: https://www.atsdr.cdc.gov/spl.
Substances To Be Evaluated for Set 31 Toxicological Profiles
Each year, ATSDR develops a list of substances to be considered for
toxicological profile development. The Set 31 nomination process
includes consideration of all substances on ATSDR's SPL, as well as
other substances nominated by the public. The 275 substances on the SPL
will be considered for Set 31 Toxicological Profile development. This
list may be found at the following Web site: https://www.atsdr.cdc.gov/spl.
Submission of Nominations for the Evaluation of Set 31 Proposed
Substances
ATSDR also will consider the nomination of any substance that is
not on the SPL under the authority of the Comprehensive, Environmental
Response, Compensation, and Liability Act (CERCLA) to ``. . . establish
and maintain an inventory of literature, research, and studies on the
health effects of toxic substances'' under CERCLA Section 104(i)(1)(B),
to respond to requests for consultation under section 104(i)(4), and to
support the site-specific response actions conducted by ATSDR, as
otherwise necessary.
Today's document invites voluntary public nominations for
substances included on the SPL and for substances not listed on the
SPL. All nominations should include the full name of the nominator,
affiliation, and email address. When nominating a non-SPL substance,
please include the rationale for the nomination. Please note that email
addresses will not be posted in the docket found at
www.regulations.gov.
ATSDR will evaluate all data and information associated with
nominated substances and will determine the final list of substances to
be chosen for toxicological profile development. Substances will be
chosen according to ATSDR's specific guidelines for selection. These
guidelines can be found in the Selection Criteria announced in the
Federal Register on May 7, 1993 (58 FR 27286). A hard copy of the
Selection Criteria is available upon request or may be accessed at:
https://www.atsdr.cdc.gov/toxprofiles/guidance/criteria_for_selecting_tp_support.pdf.
Please ensure that your comments are submitted within the specified
nomination period. Nominations received after the closing date will be
marked as late and may be considered only if time and resources permit.
Pamela I. Protzel Berman,
Associate Director, Office of Policy, Planning and Evaluation, National
Center for Environmental Health, Agency for Toxic substances and
Disease Registry.
[FR Doc. 2017-05736 Filed 3-22-17; 8:45 am]
BILLING CODE 4163-70-P
